{"paper_id":"bfe43ba7-85cd-42f4-a4e6-0e14388a6783","body_text":"C O R R E C T I O N Open Access\nTRIzol treatment of secretory phase endometrium\nallows combined proteomic and mRNA\nmicroarray analysis of the same sample in\nwomen with and without endometriosis\nAmelie Fassbender, Peter Simsa, Cleophas M Kyama, Etienne Waelkens, Attila Mihalyi, Christel Meuleman,\nOlivier Gevaert, Raf Van de Plas, Bart de Moor and Thomas M D ’Hooghe1,2,3,4*\nSince publication of our article [1], we have realised that\nwe did not include the full data in Table 1 and missed\nthe word (TOF) in the result/discussion section. We\nhave provided here the ada pted sentence and another\nversion of the table, including all the information\nintended.\nResults/Discussion\n“Therefore, we plan to repeat this study in a larger sam-\nple size including well defined endometrial samples\nobtained during menstrual, follicular and secretory\nphase, to validate the reproducibility of SELDI-TOF MS\ntechnology in these samples and to identify the protein* Correspondence: thomas.dhooghe@uzleuven.be\n1Leuven University Fertility Centre, Department of Obstetrics & Gynaecology,\nUniversity Hospital Gasthuisberg, Leuven, Belgium\nFull list of author information is available at the end of the article\nTable 1 The representative molecular weights of the proteins identified in the mRNA Microarray study [Thirteen] [2]\nProtein Mass in Da\nOsteoglycin (OGN/4969) 33,922\nInterleukin-6 signal transducer (IL6ST/3572) isoform 1 103,537\nisoform 2 37,499\nCytochrome P450, Family 2, Subfamily J, polypeptide 2 (CYP2J2/1573) 57,611\nCarboxypeptidase E (CPE/1363) 53,151\nFibronectin 1 (FN1/2335) different isoforms\n1. 262,607\n2. 71,943\n3. 259,198\n4. 222,944\n5. 243,316\n6. 240,477\n7. 268,894\n8. 252,793\n9. 246,670\n10. 239,608\n11. 262,388\n12. 221,274\n13. 249,304\n14. 249,384\nFassbender et al . Reproductive Biology and Endocrinology 2011, 9:44\nhttp://www.rbej.com/content/9/1/44\n© 2011 Fassbender et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative\nCommons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and\nreproduction in any medium, provided the original work is properly cited.\n\npeaks observed after proteomic analysis, which are\nexpensive and labour intense requiring High-performance\nliquid chromatography or high-pressure liquid chromato-\ngraphy (HPLC) and matrix assisted laser desorption ioni-\nzation Time-of-Flight-Mass Spectrometry (MALDI-TOF/\nTOF MS).”\nAuthor details\n1Leuven University Fertility Centre, Department of Obstetrics & Gynaecology,\nUniversity Hospital Gasthuisberg, Leuven, Belgium. 2Division of Reproductive\nHealth and Biology, Institute of Primate Research, P.O. Box 24481-00502\nKaren, Nairobi, Kenya. 3Biochemistry Section, Department of Molecular Cell\nBiology, Campus Gasthuisberg, Leuven, Belgium. 4Department of Electrical\nEngineering, ESAT-SCD, K.U.Leuven, Kasteelpark-Arenberg 10, B-3001\nHeverlee, Belgium.\nReceived: 29 March 2011 Accepted: 6 April 2011 Published: 6 April 2011\nReferences\n1. Fassbender Amelie, Simsa Peter, Kyama MCleophas, Waelkens Etienne,\nMihalyi Attila, Meuleman Christel, Gevaert Olivier, Van de Plas Raf, de\nMoor Bart, D ’Hooghe MThomas: TRIzol treatment of secretory phase\nendometrium allows combined proteomic and mRNA microarray\nanalysis of the same sample in women with and without endometriosis.\nReproductive Biology and Endocrinology 2010, 8:123.\n2. Sherwin JR, Sharkey AM, Mihalyi A, Simsa P, Catalano RD, D ’Hooghe TM:\nGlobal gene analysis of late secretory phase, eutopic endometrium does\nnot provide the basis for a minimally invasive test of endometriosis.\nHum Reprod 2008, 23(5):1063-1068.\ndoi:10.1186/1477-7827-9-44\nCite this article as: Fassbender et al .: TRIzol treatment of secretory\nphase endometrium allows combined proteomic and mRNA microarray\nanalysis of the same sample in women with and without\nendometriosis. Reproductive Biology and Endocrinology 2011 9:44.\nSubmit your next manuscript to BioMed Central\nand take full advantage of: \n• Convenient online submission\n• Thorough peer review\n• No space constraints or color figure charges\n• Immediate publication on acceptance\n• Inclusion in PubMed, CAS, Scopus and Google Scholar\n• Research which is freely available for redistribution\nSubmit your manuscript at \nwww.biomedcentral.com/submit\nTable 1 The representative molecular weights of the proteins identified in the mRNA Microarray study [Thirteen] [2]\n(Continued)\n15. 272,302\nSynuclein, gamma (SNCG/6623) 13,331\nBAI1-associated protein 2 (BAIAP2/10458) different isoforms\n1. 60,868\n2. 59,014\n3. 56,626\n4. 57,359\n5. 57,445\n6. 57,430\nProtocadherin 17 (PCDH17/27253) different isoforms\n1. 126,229\n2. 96,570\nProtein tyrosine phosphatase, receptor type, R (PTPRR/5801) Alpha 73,834 Da\nGamma 46,581Da\nDelta 51,046Da\nFassbender et al . Reproductive Biology and Endocrinology 2011, 9:44\nhttp://www.rbej.com/content/9/1/44\nPage 2 of 2","source_license":"CC0","license_restricted":false}